World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
121
Citations
82957
World Ranking
3534
National Ranking
1945

Overview

David H. Johnson is affiliated with The University of Texas Southwestern Medical Center in the United States. Their research focuses primarily on the field of Medicine, with extensive work in subfields including Pulmonary and Respiratory Medicine, Oncology, Sociology and Political Science, Economics and Econometrics, and Public Health, Environmental and Occupational Health.

The scientist's research topics cover a range of issues related to lung cancer and its broader social and economic impacts. Main topics include:

  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Global Cancer Incidence and Screening
  • South African History and Culture
  • Cancer Immunotherapy and Biomarkers
  • Economic and Financial Impacts of Cancer
  • Palliative Care and End-of-Life Issues

David H. Johnson has authored multiple papers in the Journal of Clinical Oncology and other high-profile journals. Notable recent publications include:

  • Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update, 2020, Journal of Clinical Oncology
  • Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update, 2021, Journal of Clinical Oncology
  • Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2022, Journal of Clinical Oncology
  • Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2022, Journal of Clinical Oncology
  • Trajectories of Health Care Contact Days for Patients With Stage IV Non-Small Cell Lung Cancer, 2024, JAMA Network Open

Frequent co-authors in their work include Sheena Bhalla, Vijaya Subbu Natchimuthu, Bryan J. Schneider, Sarah Temin, and Sherman Baker.

Their publications are often found in the following venues:

  • Journal of Clinical Oncology
  • arXiv (Cornell University)
  • Heart Rhythm
  • Journal of the National Comprehensive Cancer Network
  • JCO Oncology Practice

David H. Johnson has also contributed to book publications, including a work published by Edinburgh University Press titled Dreaming of Freedom in South Africa (2020).

Best Publications

  • Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

    Alan Sandler;Robert Gray;Michael C. Perry;Julie Brahmer

  • Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

    Joan H. Schiller;David Harrington;Chandra P. Belani;Corey Langer

  • Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

    David H. Johnson;Louis Fehrenbacher;William F. Novotny;Roy S. Herbst

  • Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

    Timothy Winton;Robert Livingston;David H Johnson;James Rigas

  • Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

    Roy S. Herbst;Giuseppe Giaccone;Joan H. Schiller;Ronald B. Natale

  • Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

    Giuseppe Giaccone;Roy S. Herbst;Christian Manegold;Giorgio Scagliotti

  • Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib

    David A. Eberhard;Bruce E. Johnson;Lukas C. Amler;Audrey D. Goddard

  • Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

    Andrew T. Turrisi;Kyungmann Kim;Ronald Blum;William T. Sause

  • American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003

    David G. Pfister;David H. Johnson;Christopher G. Azzoli;William Sause

  • TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer

    Roy S. Herbst;Diane Prager;Robert Hermann;Lou Fehrenbacher

  • Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

    Jeffrey Crawford;Howard Ozer;Ronald Stoller;David H Johnson

  • A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

    Jean Pierre Pignon;Rodrigo Arriagada;Daniel C. Ihde;David H. Johnson

  • Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

    Kathy S Albain;R Suzanne Swann;Valerie W Rusch;Andrew T Turrisi

  • [American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer].

    Christopher G. Azzoli;Sherman Baker;Sarah Temin;William Pao

  • Radiation Therapy Oncology Group (RTOG) 88–08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer

    William T. Sause;Charles Scott;Samuel Taylor;David H Johnson

  • Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer : Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

    William Sause;Patricia Kolesar;Samuel Taylor;David H Johnson

  • Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials

    Daphne W. Bell;Thomas J. Lynch;Sara M. Haserlat;Patricia L. Harris

  • Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer

    Roy S. Herbst;David H. Johnson;Eric Mininberg;David P. Carbone

  • Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Gregory A. Masters;Sarah Temin;Christopher G. Azzoli;Giuseppe Giaccone

  • Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Nasser Hanna;David H Johnson;Sarah Temin;Gregory Masters

Frequent Co-Authors

John D. Hainsworth
John D. Hainsworth Sarah Cannon Research Institute
Joan H. Schiller
Joan H. Schiller University of Virginia
F. Anthony Greco
F. Anthony Greco Sarah Cannon Research Institute
Yu Shyr
Yu Shyr Vanderbilt University Medical Center
David P. Carbone
David P. Carbone The Ohio State University
Robert B. Livingston
Robert B. Livingston University of Arizona
Frances A. Shepherd
Frances A. Shepherd Princess Margaret Cancer Centre
Leora Horn
Leora Horn Vanderbilt University Medical Center
Henry N. Wagner
Henry N. Wagner Penn State Cancer Institute
Julie R. Brahmer
Julie R. Brahmer Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA opens up diverse options beyond the traditional MD degree. Many students and professionals choose online degree programs to advance their qualifications while maintaining work-life balance. For those interested in healthcare management, consider exploring online mha programs cahme accredited for recognized, flexible graduate education in administration.

Registered nurses looking to further their careers without extensive clinical requirements can look into rn to bsn programs focused on theory, leadership, and research. If you're ready to pursue the highest level of nursing practice, there are options for the shortest dnp program online aimed at qualified candidates seeking a streamlined path.

Want to identify accessible routes to a doctoral degree in nursing? Community discussions and reviews can help you find some of the easiest dnp program reddit recommends, based on student experiences and admission flexibility. These online pathways offer valuable, accredited options to advance your healthcare career with greater convenience.

Best Scientists Citing David H. Johnson

Trending Scientists

Recently Published Articles